Edit Content

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Retinal Biologics Market to reach USD XX billion by the end of 2030

Global Retinal Biologics Market Size Study & Forecast, by Drug Class (VEGF-A Antagonist, TNF-a Inhibitor), by Disease Indication (Macular Degeneration, Diabetic Retinopathy, Uveitis, Other Disease Indications), and Regional Analysis, 2023-2030

Product Code: HLSB-10892560
Publish Date: 10-03-2024
Page: 200

Global Retinal Biologics Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.8% during the forecast period 2023-2030. Retinal biologics are specialized treatments for retinal diseases that employ biological substances such as proteins, antibodies, gene therapy, or cell-based therapies. These innovative therapies target specific pathways involved in conditions such as age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion Derived from living organisms such as proteins or antibodies, these biologics are meticulously designed to target precise molecules or processes implicated in retinal diseases. By homing in on the underlying mechanisms, they offer targeted therapies that surpass conventional approaches in efficacy. Administered primarily through intravitreal injections, the delivery method ensures direct application of the medication into the eye, optimizing treatment precision and efficacy. The Retinal Biologics Market is expanding because of factors such as the rising number of FDA approvals, increasing healthcare expenditure, coupled with the growing aging population. The Retinal Biologics Market is poised for growth due to the introduction of diverse drug products aimed at treating retinal diseases, which is fostering increased competition in the market.

In addition, the prevalence of vision impairments, including diabetic retinopathy is to further stimulate market demand across the globe. According to a 2023 report by the World Health Organization (WHO), approximately 2.2 billion individuals globally are affected by either distant or near vision impairments, underscoring the urgent need for effective treatments in the retinal biologics market. Also, according to the study conducted by National Institute of Health (NIH) titled “Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis,” published in November 2021, the global prevalence of diabetic retinopathy among adults stood at an estimated 103.12 million in 2020. Projections suggest that by 2045, this figure rise substantially to reach 160.50 million individuals. This escalation in the prevalence of retinal diseases or diabetic retinopathy is anticipated to fuel demand for biological treatments, consequently propelling the growth of the Retinal Biologics Market during the estimated period of 2023-2030. Moreover, the rising innovation in biotechnology and drug development, as well as the growing investment in research and development present various lucrative opportunities over the forecast years. However, the high initial capital investment and stringent regulatory process are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Retinal Biologics Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing R&D activities and the growing number of FDA approvals. The market in this region is expected to witness further growth, supported by the presence of major players. Moreover, key stakeholders in the region are implementing various strategies such as acquisitions, product launches, and partnerships to fortify their positions. For instance, in June 2020, Novartis announced the U.S. FDA’s approval for a label update for Beovu, which includes the addition of a subsection dedicated to retinal vasculitis or retinal vascular occlusion under ‘Warnings and Precautions’. Similarly in September 2021, the U.S. FDA approved the first biosimilar, Byooviz, for the treatment of macular degeneration disease. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The increasing prevalence of retinal diseases, the growing burden of the diabetic population, as well as advancements in biotechnology and drug development, are significantly propelling the market demand across the region.

Major market players included in this report are:
F. Hoffmann-La Roche Ltd
Regeneron Pharmaceuticals Inc.
AbbVie Inc.
MeiraGTx Limited
Oxurion NV
Novartis AG
GenSight Biologics S.A.
Adverum Biotechnologies Inc
SemaThera Inc.
Amgen Inc.

Recent Developments in the Market:
Ø In August 2023, Regeneron Pharmaceuticals, Inc. received approval from the U.S. FDA for an EYLEA HD injection. This approval encompasses its application in treating conditions such as diabetic retinopathy, wet age-related macular degeneration, and diabetic macular edema.
Ø In March 2023, Praetego Inc. secured funding of USD 300 million from the National Eye Institute. This financial support aims to propel the development of pioneering oral medications designed specifically for diabetic retinopathy.
Ø In April 2022, Shilpa Biologicals (SBPL) obtained a No Objection Certificate (NoC) from RCGM, Department of Biotechnology, enabling it to approach the Drugs Controller General of India (DCGI) to conduct clinical studies for its Biosimilar Aflibercept. This initiative targets the markets for Wet Age-Related Macular Degeneration (wAMD), Diabetic Retinopathy, Diabetic Macular Edema (DME), and Macular Edema following Retinal Vein Occlusion, both in India and globally.

Global Retinal Biologics Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Drug Class, Disease Indication, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:
VEGF-A Antagonist
TNF-a Inhibitor

By Disease Indication:
Macular Degeneration
Diabetic Retinopathy
Other Disease Indications

By Region:

North America


Asia Pacific
South Korea

Latin America

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Retinal Biologics Market, by Region, 2020-2030 (USD Billion)
1.2.2. Retinal Biologics Market, by Drug Class, 2020-2030 (USD Billion)
1.2.3. Retinal Biologics Market, by Disease Indication, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Retinal Biologics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Retinal Biologics Market Dynamics
3.1. Retinal Biologics Market Impact Analysis (2020-2030)
3.1.1. Market Drivers Increasing introduction of diverse drug products Rising prevalence of vision impairments
3.1.2. Market Challenges High initial capital investment Stringent regulatory process
3.1.3. Market Opportunities Rising innovation in biotechnology and drug development Growing investment in research and development
Chapter 4. Global Retinal Biologics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Retinal Biologics Market, by Drug Class
5.1. Market Snapshot
5.2. Global Retinal Biologics Market by Drug Class, Performance – Potential Analysis
5.3. Global Retinal Biologics Market Estimates & Forecasts by Drug Class 2020-2030 (USD Billion)
5.4. Retinal Biologics Market, Sub Segment Analysis
5.4.1. VEGF-A Antagonist
5.4.2. TNF-a Inhibitor
Chapter 6. Global Retinal Biologics Market, by Disease Indication
6.1. Market Snapshot
6.2. Global Retinal Biologics Market by Disease Indication, Performance – Potential Analysis
6.3. Global Retinal Biologics Market Estimates & Forecasts by Disease Indication 2020-2030 (USD Billion)
6.4. Retinal Biologics Market, Sub Segment Analysis
6.4.1. Macular Degeneration
6.4.2. Diabetic Retinopathy
6.4.3. Uveitis
6.4.4. Other Disease Indications
Chapter 7. Global Retinal Biologics Market, Regional Analysis
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Retinal Biologics Market, Regional Market Snapshot
7.4. North America Retinal Biologics Market
7.4.1. U.S. Retinal Biologics Market Drug Class breakdown estimates & forecasts, 2020-2030 Disease Indication breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Retinal Biologics Market
7.5. Europe Retinal Biologics Market Snapshot
7.5.1. U.K. Retinal Biologics Market
7.5.2. Germany Retinal Biologics Market
7.5.3. France Retinal Biologics Market
7.5.4. Spain Retinal Biologics Market
7.5.5. Italy Retinal Biologics Market
7.5.6. Rest of Europe Retinal Biologics Market
7.6. Asia-Pacific Retinal Biologics Market Snapshot
7.6.1. China Retinal Biologics Market
7.6.2. India Retinal Biologics Market
7.6.3. Japan Retinal Biologics Market
7.6.4. Australia Retinal Biologics Market
7.6.5. South Korea Retinal Biologics Market
7.6.6. Rest of Asia Pacific Retinal Biologics Market
7.7. Latin America Retinal Biologics Market Snapshot
7.7.1. Brazil Retinal Biologics Market
7.7.2. Mexico Retinal Biologics Market
7.8. Middle East & Africa Retinal Biologics Market
7.8.1. Saudi Arabia Retinal Biologics Market
7.8.2. South Africa Retinal Biologics Market
7.8.3. Rest of Middle East & Africa Retinal Biologics Market

Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. F. Hoffmann-La Roche Ltd Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
8.3.2. Regeneron Pharmaceuticals Inc.
8.3.3. AbbVie Inc.
8.3.4. MeiraGTx Limited
8.3.5. Oxurion NV
8.3.6. Novartis AG
8.3.7. GenSight Biologics S.A.
8.3.8. Adverum Biotechnologies Inc
8.3.9. SemaThera Inc.
8.3.10. Amgen Inc.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now